Epilepsy Medical Education Grant
Jazz Pharmaceuticals (Jazz) is committed to improving patient outcomes and providing support in compliance with local regulations.
Epilepsy
- Timely screening, identification, diagnosis, and optimal seizure management of Lennox-Gastaut Syndrome (LGS) and other developmental and epileptic encephalopathies (DEEs), especially in adult patients
- Comprehensive management of patients with DEEs including symptoms beyond seizures
- Improving adherence to and persistence with antiseizure medications in DEEs including initiation titration, AE and DDI management and optimizing efficacy
Jazz Pharmaceuticals (JAZZ) is committed to advancing scientific knowledge and clinical expertise within the medical and scientific communities with the ultimate goal of improving patient care.
This site allows you to submit Independent Medical Education (IME) requests for US and Ex-US activities or initiatives that serve to maintain, develop, or increase the knowledge, skills, and/or professional performance of healthcare professionals (e.g., continuing medical education, continuing health education, continuing education).
IME is supported education (accredited or non-accredited) in which JAZZ exercises no control, influence, or direction over any aspect of the program, including but not limited to educational design, faculty, authors, speakers, etc. All grants must comply with local regulations.
We are currently accepting requests for:
- Meetings, Conferences, or Symposia
- Medical Center Grand Rounds lectures
- Fellowships
- Enduring IME activities, which may include strategies, tools, and other educational resources to use with patients
- Patient education in conjunction with Health Care Provider (HCP) education
PIRA™ proposals are AI generated and are not reviewed or endorsed by the sponsoring company.
Proposed: Breakfast Symposium in April 2026 at ZZ Hospital
Title
Advancing Adult Care in Lennox–Gastaut Syndrome and Developmental and Epileptic Encephalopathies: Early Identification, Comprehensive Management, and Optimized Therapeutic Strategies
Overview
This accredited breakfast symposium will address emerging challenges in the recognition and management of Lennox–Gastaut syndrome (LGS) and other developmental and epileptic encephalopathies (DEEs), with a specific focus on adult patients whose evolving clinical presentations often lead to delayed diagnosis and suboptimal care. The session will integrate current evidence, case-based learning, and patient-centered perspectives to support clinicians in improving outcomes across the lifespan.
Educational Need
Adult patients with DEEs experience fragmented transition of care, incomplete historical documentation, and evolving seizure phenotypes that complicate timely identification and treatment. There is a recognized need for earlier screening strategies, more accurate diagnostic approaches, and improved therapeutic management that incorporates both seizure and non-seizure symptoms. Additionally, adherence and persistence challenges remain significant due to complex titration schedules, adverse effects, and drug–drug interactions.
Learning Objectives
Participants will be able to:
-
Apply current best practices for screening, identification, and diagnosis of LGS and other DEEs—particularly in adults with previously unrecognized or evolving clinical features.
-
Implement comprehensive management strategies that address seizure control as well as behavioral, cognitive, sleep, and psychosocial comorbidities commonly observed in DEEs.
-
Optimize adherence and persistence with antiseizure medications (ASMs) through improved titration practices, adverse event mitigation, drug–drug interaction management, and patient/caregiver engagement.
Proposed Agenda (60 minutes)
Welcome and Breakfast (5 minutes)
Brief introduction and overview of unmet needs in adult DEEs.
Session 1: Early Recognition and Evolving Presentation of LGS and Other DEEs in Adulthood (20 minutes)
Presented by an adult neurologist specializing in DEEs
Topics include:
– Diagnostic challenges when pediatric histories are incomplete
– Atypical seizure patterns and EEG features in adult patients
– Practical screening and referral pathways
Session 2: Beyond Seizures: Comprehensive and Lifelong Management of DEEs (20 minutes)
Presented by a representative from a national patient advocacy organization
Topics include:
– Behavioral and cognitive comorbidities
– Sleep disturbances, mobility issues, communication barriers
– Transition-of-care considerations
– Caregiver burden and support frameworks
Session 3: Improving ASM Adherence and Persistence in Complex DEEs (10 minutes)
Presented by the physician faculty member
Topics include:
– Strategies for initiation and titration
– Anticipating and managing adverse effects and drug–drug interactions
– Supporting long-term efficacy through patient and caregiver education
Panel Q&A (5 minutes)
Interactive discussion addressing real-world challenges in adult DEE care.
Proposed Faculty
-
Adult epileptologist with clinical expertise in LGS and other DEEs
-
Representative from a recognized DEE-focused patient advocacy organization
Target Audience
Adult neurologists, epileptologists, pediatric neurologists involved in transition of care, advanced practice providers, pharmacists, and other clinicians managing patients with complex epilepsies.
Estimated Budget and Support Request
A detailed budget can be provided upon request. Support will cover faculty honoraria, event logistics, venue and audiovisual services, accreditation fees, and educational materials.
This symposium will provide clinicians with practical tools to improve care delivery for adults living with DEEs, integrating both clinical and patient-centered perspectives to enhance diagnostic accuracy, treatment adherence, and overall quality of life.